The use of I-131-fibrinogen in the diagnosis of venous thrombosis and in the evaluation of the effect of anticoagulant treatment
Van der Maas, A.P.; Teulings, F.A.; Schopman, W.; den Ottolander, G.J.
Nederlands Tijdschrift Voor Geneeskunde 117(37): 1388-1396
1973
ISSN/ISBN: 0028-2162 PMID: 4787074 Document Number: 69648
Document emailed within 1 workday
Related Documents
Gschwandtner, M.E.; Eichinger, S.; Hütter, D.; Korninger, L.; Lechner, K.; Panzer, S.; Pabinger, I. 1996: Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 7(3): 325-330Wosornu, L.; Dlamini, A.; Mikolaijkov, A.T. 1978: Diagnosis of venous thrombosis using 125 I-fibrinogen in Zambia Medical Journal of Zambia 12(3): 69-72
Lehmer, R.R.; Elias, A.N.; Capdeville, M.J.; Brown, D.R.; Branson, H.E. 1985: Fibrinogen Irvine: a qualitatively abnormal fibrinogen associated with the predisposition to recurrent visceral and peripheral venous thrombosis Journal of the National Medical Association 77(7): 561-565
Barbanti, M.; Calanni, F.; Milani, M.R.; Marchi, E.; Semeraro, N.; Colucci, M. 1993: Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis--evidence for an anticoagulant-independent mechanism Thrombosis and Haemostasis 69(2): 147-151
Burnayeva, S.V.; Vasilyeva, I.I.; Gavrisyuk, V.K.; Gerasimenko, S.I.; Gudz, I.M.; Dzyublik, A.Ya.; Dzyak, G.V.; Zharinov, O.I.; Kobza, I.I.; Kovalev, A.A.; Kolesnik, E.A.; Kostylev, M.V.; Kulik, I.V.; Lutay, Y.M.; Mishalov, V.G.; Mishchenko, T.S.; Nikonenko, A.S.; Nikonenko, A.A.; Nikulnikov, P.I.; Parkhomenko, A.N.; Polulyakh, M.V.; Rudenko, K.V.; Skupoy, O.M.; Tatarchuk, T.F.; Todurov, B.M.; Usenko, A.Yu.; Feshchenko, Y.I.; Chernukha, I.M.; Yachnik, A.I. 2017: The Experts Consensus for Anticoagulant Therapy of Venous Thromboembolism in 2016 Yr. Significance of the Rivaroxaban Investigations Program for Changes of Approaches, Concerning Treatment of the Deep Veins Thrombosis and Pulmonary Thromboembolism Klinichna Khirurhiia 2017(3): 65-80
Jacq, F.; Héron, E.; Rance, A.; Césarini, M.L.; Emmerich, J.; Fiessinger, J.N. 1997: Evaluation of a test for rapid detection of D-dimers for the exclusion of the diagnosis of venous thrombosis Presse Medicale 26(24): 1132-1134
Bai, C.; Pan, J.; Fan, L. 2000: A study on the deficiency of anticoagulant proteins in Chinese patients with deep venous thrombosis Zhonghua Nei Ke Za Zhi 39(11): 746-748
Sørensen, M.D.; Ott, P.; Gad, I.; Gyhrs, S.; Iversen, D.; Treufeldt, P. 1988: Fibrin and fibrinogen degradation products in suspected deep venous thrombosis of the lower extremities Ugeskrift for Laeger 150(1): 20-22
Li, B.; Zhang, J.; Yin, L. 1998: Diagnosis and endovascular treatment of multiple thrombosis in cerebral venous sinus Zhonghua Yi Xue Za Zhi 78(2): 128-130
Levine, M.N. 2001: Management of venous thrombosis in cancer. Recent developments in diagnosis, prevention, and treatment Tumori 87(2): S24-S26
Hedlund, P.O.; Sjögren, S. 1970: Clinical experience in the diagnosis of thrombosis by use of 125 I-fibrinogen Nordisk Medicin 84(30): 952-953
Vuillemenot, A.; Bassand, J.P. 1994: Deep venous thrombosis of the lower limbs. Etiology, physiopathology, diagnosis, course, prognosis, treatment La Revue du Praticien 44(1): 109-117
Lévesque, H.; Cailleux, N.; Vasse, D.; Legallicier, B.; Moore, N.; Borg, J.Y.; Hantute, N.; Thuillez, C.; Courtois, H. 1994: Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients Therapie 49(2): 101-105
Prountjos, P.; Bastounis, E.; Hadjinikolaou, L.; Felekuras, E.; Balas, P. 1991: Superficial venous thrombosis of the lower extremities co-existing with deep venous thrombosis. a phlebographic study on 57 cases International Angiology: a Journal of the International Union of Angiology 10(2): 63-65
Koopman, K.; Uyttenboogaart, M.; Vroomen, P.C.A.J.; van der Meer, J.; De Keyser, J.; Luijckx, G-Jan. 2009: Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years Thrombosis and haemostasis 102(4): 620-622
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Arnesen, H.; Ly, B. 1979: Diagnosis and treatment of recent deep venous thrombosis and recent pulmonary embolism Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 99(12): 591-593
Tschopp, J.F.; Mazur, C.; Gould, K.; Connolly, R.; Pierschbacher, M.D. 1994: Inhibition of thrombosis by a selective fibrinogen receptor antagonist without effect on bleeding time Thrombosis and Haemostasis 72(1): 119-124
Surendrababu, N.R.S.; Subathira; Livingstone, R.S. 2006: Variations in the cerebral venous anatomy and pitfalls in the diagnosis of cerebral venous sinus thrombosis: low field MR experience Indian Journal of Medical Sciences 60(4): 135-142
Stefanović, L. 1976: Clinical value and technics of diagnosis of deep vein thrombosis of the lower extremities by means of radioactive iodine-labeled fibrinogen Medicinski Pregled 29(9-10): 441-447